ENCOURAGING RESULTS FROM A SCIENTIFIC COLLABORATION BETWEEN HELSINKI UNIVERSITY HOSPITAL, RAYSEARCH AND MICROPOS

We are pleased to announce that ESTRO (the European SocieTy for Radiotherapy and Oncology) has now published online the electronic poster, Reconstruction of Intra-Fractional Prostate Movement and Its Effect on Dose Distribution, for the coming autumn ESTRO 2020 congress in Vienna, Austria.

The aim of the study was to retrospectively reconstruct the dose distributions for five (5) patients at Helsinki University Hospital, Finland, having intra-fractional prostate movement exceeding 3 mm. The reconstruction was done by using a research version of RayStation treatment planning system (RaySearch Laboratories, Sweden) and motion data from the RayPilot system (Micropos Medical, Sweden) recorded during hypofractionated treatment sessions. The study demonstrated that both dose to the prostate (target) and undesired dose to rectum and bladder (potential side effects) are significantly depending on prostate movement.

”This study shows the potential of RayPilot as an important enhancer of radiation cancer treatment and data like this helps to build awareness of what a real time tracking system in routine use potentially can do for the cancer patients’ outcome ”, comments Thomas Lindström, CEO of Micropos Medical.

We are pleased of this three part research collaboration with each part contributing its own extensive and deep expertise and a great collaboration throughout the study.

Please contact us by e-mail: info@micropos.se for your own copy of the poster.